CMMB

Chemomab Therapeutics
CMMB

Overview Fund Activity

12 hedge funds and large institutions have $3.34M invested in Chemomab Therapeutics in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 3 closing their positions.

Holders
12
Holders Change
-2
Holders Change %
-14.29%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RhumbLine Advisers
1
RhumbLine Advisers
Massachusetts
$3.94K

Top Sellers

1
CAM
1
Cormorant Asset Management
Massachusetts
$0
2
Two Sigma Investments
2
Two Sigma Investments
New York
$0
3
IC
3
Ikarian Capital
Texas
$280K
4
Two Sigma Advisers
4
Two Sigma Advisers
New York
$0
5
Morgan Stanley
5
Morgan Stanley
New York
$132
Name Market Value Shares Shares
Change 		Shares
Change %
O
1
OrbiMed
New York
$2.95M 2,241,274 – –
IC
2
Ikarian Capital
Texas
$280K 213,392 -23,317 -10%
KPWS
3
Kestra Private Wealth Services
Texas
$41.1K 31,241 – –
BFM
4
Boothbay Fund Management
New York
$34.9K 26,529 – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$15.4K 11,737 – –
ASN
6
Advisory Services Network
Georgia
$14.7K 11,173 – –
RhumbLine Advisers
7
RhumbLine Advisers
Massachusetts
$3.94K 3,005 +3,005 New
Osaic Holdings
8
Osaic Holdings
Arizona
$3.58K 2,725 – –
NFSG
9
Newbridge Financial Services Group
Florida
$1.45K 1,100 – –
Morgan Stanley
10
Morgan Stanley
New York
$132 100 -7,700 -99%
UBS Group
11
UBS Group
Switzerland
$16 12 -399 -97%
CAM
12
Cormorant Asset Management
Massachusetts
– – -288,169 Closed
Two Sigma Investments
13
Two Sigma Investments
New York
– – -30,263 Closed
Two Sigma Advisers
14
Two Sigma Advisers
New York
– – -11,800 Closed
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$0 246 – –
CFGS
16
Concourse Financial Group Securities
Alabama
– – – –